Questions of preparing patients for joint replacement: what does a therapist need to know?


DOI: https://dx.doi.org/10.18565/therapy.2021.1.83-89

Amirdzhanova V.N., Pogozheva E.Yu.

V.A. Nasonova Research Institute of Rheumatology, Moscow
Abstract. Article discusses the key aspects of preparing patients with large joints pathology for arthroplasty in therapeutic practice: rational use of non-steroidal anti-inflammatory medicines for chronic pain control, prevention of postoperative infectious complications, venous thrombosis and bone fractures associated with the development of osteoporosis.
Keywords: replacement arthroplasty, rheumatoid arthritis, osteoarthritis, infectious complications, venous thrombosis, non-steroidal anti-inflammatory medicines
Read entire article

Literature


  1. Российские клинические рекомендации. Ревматология. Под ред. Е.Л. Насонова. М.: ГЭОТАР-Медиа. 2017; 464 с. ISBN 978-5-9704-4261-6. [Russian clinical guidelines. Rheumatology. Ed. by Nasonov E.L. Moscow: GEOTAR-Media. 2017; 464 pp. ISBN 978-5-9704-4261-6 (In Russ.)].

  2. Mariorenzi M., Levins J., Marcaccio S. et al. Outpatient total joint arthroplasty: A review of the current stance and future direction. R I Med J (2013). 2020; 103(3): 63–67.

  3. Амирджанова В.Н., Макаров М.А., Бялик Е.И. с соавт. Периоперационное ведение больных ревматоидным артритом. Научно-практическая ревматология. 2014; 4: 366–375. [Amirdzhanova V.N., Makarov M.A., Byalik E.I. et al. Perioperative management of patients with rheumatoid arthritis. Nauchno-prakticheskaya revmatologiya = Scientific and practical rheumatology. 2014; 4: 366–375 (In Russ.)]. doi: https://dx.doi.org/10.14412/1995-4484-2014-366-375.

  4. Goodman S.M., Johnson B., Zhang M. et al. Patients with rheumatoid arthritis have similar excellent outcomes after total knee replacement compared with patients with osteoarthritis. J Rheumatol. 2016; 43(1): 46–53. doi: 10.3899/jrheum.150525.

  5. Smolen J.S., Aletaha D., Bijlsma J.W. et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010; 69(4): 631–37. doi: 10.1136/ard.2009.123919.

  6. McCartney C.J., Nelligan K. Postoperative pain management after total knee arthroplasty in elderly patients: treatment options. Drugs Aging. 2014; 31(2): 83–91. doi: 10.1007/s40266-013-0148-y.

  7. Diaz-Heredia J., Loza E., Cebreiro I., Ruiz Iban M.A. Preventive analgesia in hip or knee arthroplasty: a systematic review. Rev Esp Cir Ortop Traumatol. 2015; 59(2): 73–90. doi: 10.1016/j.recot.2014.09.004.

  8. Jiang M., Deng H., Chen X. et al. The efficacy and safety of selective COX-2 inhibitors for postoperative pain management in patients after total knee/hip arthroplasty: a meta-analysis. J Orthop Surg Res. 2020; 15(1): 39. doi: 10.1186/s13018-020-1569-z.

  9. Ravi B., Croxford R., Hollands S. et al. Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis. Arthritis Rheumatol. 2014; 66(2): 254–63. doi: 10.1002/art.38231.

  10. Fleisher L.A., Beckman J.A., Brown K.A. et al. 2009 ACCF/AHA focused update on perioperative b blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2009; 120(21): e169–276. doi: 10.1161/CIRCULATIONAHA.109.192690.

  11. Gargiulo G., Capodanno D., Longo G. et al. Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomes. Expert Rev Cardiovasc Ther. 2014; 12(10): 1185–203. doi: 10.1586/14779072.2014.964687.

  12. Falck-Ytter Y., Francis C.W., Johanson N.A. et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012; 141(2 Suppl): e278S–e325S. doi: 10.1378/chest.11-2404.

  13. Храмов А.Э., Макаров М.А., Бялик Е.И. с соавт. Проблемы диагностики, профилактики и лечения перипротезной инфекции у больных ревматическими заболеваниями. Научно-практическая ревматология. 2015; 5: 558–563. [Khramov A.E., Makarov M.A., Bialik E.I. et al. Problems of diagnosis, prevention and treatment of periprosthetic infection in patients with rheumatic diseases. Nauchno-prakticheskaya revmatologiya = Scientific and practical rheumatology, 2015; 5: 558–563 (In Russ.)]. doi: https://dx.doi.org/10.14412/1995-4484-2015-558-563.

  14. Bongartz T., Halligan C.S., Osmon D.R. et al. Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum. 2008; 59(12): 1713–20. doi: 10.1002/art.24060.

  15. Strand V., Ahadieh S., French J. et al. Systematic review and meta-analysis of serious infections with tofacitinib and biologic diseasemodifying antirheumatic drug treatment in rheumatoid arthritis clinical trials. Arthritis Res Ther. 2015; 17: 362. doi: 10.1186/s13075-015-0880-2.

  16. Singh J.A., Cameron C., Noorbaloochi S. et al. Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis. Lancet. 2015; 386(9990): 258–65. doi: 10.1016/S0140-6736(14)61704-9.

  17. Somayaji R., Barnabe C., Martin L. Risk factors for infection following total joint arthroplasty in rheumatoid arthritis. Open Rheumatol J. 2013; 7: 119–24.

  18. Prince J.M., Bernatz J.T., Binkley N. et al. Changes in femoral bone mineral density after total knee arthroplasty: a systematic review and meta-analysis. Arch Osteoporos. 2019; 14(1): 23. doi: 10.1007/s11657-019-0572-7.

  19. Pires R.E., Kfuri M. Setting yourself up for success: Locked plating in periprosthetic fractures about total knee arthroplasty. J Orthop Trauma. 2019; 33 Suppl 6: S25–S28. doi: 10.1097/BOT.0000000000001565.

  20. Погожева Е.Ю., Амирджанова В.Н., Макаров С.А. Клиническая характеристика больных с ревматическими заболеваниями (РЗ), которым проводилось эндопротезирование суставов на фоне терапии генно-инженерными биологическими препаратами (ГИБП). Научно-практическая ревматология. 2013; S (VI съезд ревматологов России): 120–121. [Pogozheva E.Yu., Amirdzhanova V.N., Makarov S.A. Clinical characteristics of patients with rheumatic diseases who underwent joint replacement during therapy with genetically engineered biological drugs. Nauchno-prakticheskaya revmatologiya = Scientific and practical rheumatology2013; S (VI Congress of rheumatologists of Russia): 120–121 (In Russ.)].

  21. Савенкова Н.А., Амирджанова В.Н., Макаров С.А. с соавт. Отменять ли базисную терапию больным ревматоидным артритом перед эндопротезированием суставов? Научно-практическая ревматология. 2011; 5: 46–50. [Savenkova N.A. Amirdzhanova V.N., Makarov S.A. et al. Should I cancel basic therapy for patients with rheumatoid arthritis before joint replacement? Nauchno-prakticheskaya revmatologiya = Scientific and practical rheumatology. 2011; 5: 46–50 (In Russ.)]. doi: https://dx.doi.org/10.14412/1995-4484-2011-1460.

  22. Погожева Е.Ю., Амирджанова В.Н., Макаров С.А., Насонов Е.Л. Осложнения после эндопротезирования суставов у пациентов, получающих генно-инженерные биологические препараты. Научно-практическая ревматология. 2012; 3: 43–49. [Pogozheva E.Yu., Amirdzhanova V.N., Makarov S.A., Nasonov E.L. Complications after joint replacement in patients receiving genetically engineered biological drugs. Nauchno-prakticheskaya revmatologiya = Scientific and practical rheumatology. 2012; 3: 43–49 (In Russ.)]. doi: https://dx.doi.org/10.14412/1995-4484-2012-708.

  23. Goodman S.M., Springer B., Guyatt G. et al. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons. Guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. J Arthroplasty. 2017; 32(9): 2628–38. doi: 10.1016/j.arth.2017.05.001.

  24. Marik P.E., Varon J. Requirement of perioperative stress doses of corticosteroids: a systematic review of the literature. Arch Surg. 2008; 143(12): 1222–26. doi: 10.1001/archsurg.143.12.1222.


About the Autors

Vera N. Amirdzhanova, MD, leading researcher of the laboratory of pathophysiology of pain and polymorphism of musculoskeletal diseases, V.A. Nasonova Research Institute of Rheumatology. Address: 115522, Moscow, 34A Kashirskoe highway. Tel.: +7 (916) 613-64-39. Е-mail: amirver@yandex.ru. ORCID: 0000-0001-5382-6357
Elena Yu. Pogozheva, PhD, senior researcher of the laboratory of pathophysiology of pain and polymorphism of musculoskeletal diseases, V.A. Nasonova Research Institute of Rheumatology. Address: 115522, Moscow, 34A Kashirskoe highway. Tel.: +7 (903) 105-99-04. Е-mail: pogogenok@mail.ru. ORCID: 0000-0001-5103-5447

Back to Content

Бионика Медиа